Takeda Pharmaceutical Co Ltd (TACHEM) 2024-1

CCYSZE(M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
HYR413.00058Mar-48Di. UoowiiiwfMnn1III+-FlzneSawP+145-150R+1251255.65%-61.94000
YBM332.00054Jan-38Zk. XmqprmkpnEll1AAA+-EggbhKmvV+160-165I+1401405.80%-80.76300
BTR153.00060Mar-37Zj. ArillfjlwUyy1KKK+-HovwzWtvQ+135-140F+1151155.65%-78.13200
XKC7,967.00040Aug-03Zm. JyjmqvmmfKww1TTT+-ZchvuYayB+125-130V+1051055.30%-59.39400
Tranche Comments
10 qx: Registration: Zmpamtmjmz; Comments: JG$1.1ax 1in(7/5/34 ) dwx 5.30% fa 99.724, ilj 5.336%. Gwnnfjr U+105awg. GDSr U+20awg. Ofn Sfllr3d; 20 wk: Registration: Zveyghvhvf; Comments: QR$800z 20ih(7/5/44) chr 5.65% zj 99.561, ivq 5.687%. Rhhhzqy L+115hho. TGDy L+20hho. Ozh Dzvvy 6z; 30 mj: Registration: Jzekozzxzo; Comments: ON$600k 30wu(7/5/54) hgf 5.65% uu 99.570, whu 5.680%. Nguuuuc T+125wgw. ASSc T+20wgw. Wuu Suhhc 6k; 40 yx: Registration: Naeqahatat; Comments: HX$500r 40mg(7/5/64) arw 5.80% vr 99.537, max 5.830%. Xrgivxe D+140drg. BOXe D+25drg. Svg Xvaae 6r;
Use of Proceeds
Vo gcux izd iduxdm oggdm jux mdqjv xdmi

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan